|Bid||31.76 x 900|
|Ask||31.77 x 800|
|Day's Range||31.63 - 32.69|
|52 Week Range||24.47 - 33.58|
|Beta (3Y Monthly)||0.26|
|PE Ratio (TTM)||13.91|
|Earnings Date||Jul 31, 2019|
|Forward Dividend & Yield||1.48 (4.53%)|
|1y Target Est||32.97|
Acquisition of seniors housing portfolio valued at $1.8 billion, including construction in progress, will likely help Ventas (VTR) in diversifying its assets, business model and operator base.
HCP's amended and restated credit helps increase the size of the facility, extend the maturity date, lower the borrowing costs and boost financial flexibility.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Many investors are still learning about the various metrics that can be useful when analysing a stock...
HCP's first-quarter 2019 results indicate decent performance of the company's life-science and medical-office segments. Yet, tepid performance of seniors-housing portfolio remains a drag.
HCP (HCP) delivered FFO and revenue surprises of 2.33% and -1.34%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
HCP's premium MOB and life-sciences portfolio will likely perform well in first-quarter 2019, mitigating the challenges tormenting the senior housing market.
Healthcare Realty's (HR) latest public offering of common stock will improve its financial flexibility and provide ample scope for deploying capital in accretive acquisitions.
NEW YORK, Feb. 15, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.
HCP's fourth-quarter 2018 results marred by continued decline in senior-housing operating portfolio cash net operating income.
HCP (HCP) delivered FFO and revenue surprises of 0.00% and -1.33%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
As HCP remains focused on reducing its Brookdale-portfolio concentration, we anticipate the company to report lower portfolio occupancy in the fourth quarter.
January was a good month for healthcare REITs, pushing these names and others up sharply. But was something special going on?